Home > Insider Trading > Filing (0001209191-15-074308)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1527599	Mirna Therapeutics Inc.	MIRN	Pharmaceutical Preparations (2834)	261824804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1270521	Kittu Krishna Kolluri	1954 Greenspring Drive Suite 600 Timonium MD 21093		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-10-05	1,241,650	$0.00	1,241,650	No	4	C	Indirect	See Note 2
Common Stock	Acquisiton	2015-10-06	257,516	$0.00	1,499,166	No	4	J	Indirect	See Note 2
Common Stock	Acquisiton	2015-10-05	583,559	$0.00	2,082,725	No	4	C	Indirect	See Note 2
Common Stock	Acquisiton	2015-10-06	31,650	$0.00	2,114,375	No	4	J	Indirect	See Note 2
Common Stock	Acquisiton	2015-10-06	857,142	$7.00	2,971,517	No	4	P	Indirect	See Note 2

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Note 2
No	4	J	Indirect	See Note 2
No	4	C	Indirect	See Note 2
No	4	J	Indirect	See Note 2
No	4	P	Indirect	See Note 2

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series C Preferred Stock	Disposition	2015-10-05	1,241,650	$0.00	1,241,650	$0.00
Common Stock	Series D Preferred Stock	Disposition	2015-10-05	583,559	$0.00	583,559	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Each share of Series C Preferred Stock automatically converted on a one-to-one basis into Common Stock upon the consummation of the Issuer's initial public offering.
The Reporting Person is a director of NEA 14 GP, LTD, which is the sole general partner of NEA Partners 14, L.P. ("NEA Partners 14"). NEA Partners 14 is the sole general partner of New Enterprise Associates 14, L.P. ("NEA 14"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 shares in which the Reporting Person has no pecuniary interest.
The shares were issued for no additional consideration pursuant to an accruing paid-in-kind dividend on shares of Series C Preferred Stock of the Company.
Each share of Series D Preferred Stock automatically converted on a one-to-one basis into Common Stock upon the consummation of the Issuer's initial public offering.
The shares were issued for no additional consideration pursuant to an accruing paid-in-kind dividend on shares of Series D Preferred Stock of the Company.
Due to a clerical error, the Reporting Person's Form 3 which previously reported the holding of these shares understated his total by one (1) share.
The expiration date is not relevant to the conversion of these securities.